Financing Transaction (Additional Information) (Details)
|
|
|
|
|
|
1 Months Ended |
6 Months Ended |
|
|
|
|
|
Jun. 05, 2026
USD ($)
$ / shares
shares
|
Jun. 04, 2026
$ / shares
shares
|
Aug. 20, 2025
USD ($)
$ / shares
shares
|
May 13, 2025
USD ($)
$ / shares
|
Nov. 08, 2023
USD ($)
Segment
Days
$ / shares
shares
|
Nov. 30, 2025
USD ($)
$ / shares
shares
|
Jun. 30, 2026
USD ($)
Days
Warrants
$ / shares
shares
|
Jun. 30, 2025
USD ($)
|
May 15, 2026
shares
|
Dec. 31, 2025
$ / shares
shares
|
Nov. 06, 2025 |
Dec. 31, 2023
$ / shares
shares
|
| Subsidiary or Equity Method Investee [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock, shares issued | shares |
|
|
|
|
|
|
68,683,000
|
|
|
61,580,000
|
|
|
| Common stock, par value | $ / shares |
|
|
|
|
|
|
$ 0.0001
|
|
|
$ 0.0001
|
|
|
| Proceeds from issuance of common stock |
|
|
|
|
|
|
$ 114,999,000
|
$ 0
|
|
|
|
|
| Common stock, shares outstanding | shares |
|
|
|
|
|
|
68,683,000
|
|
|
61,580,000
|
|
|
| Advance condition |
|
|
|
|
The Company’s right to request Advances is conditioned upon the Company achieving a minimum of one new passenger auto-original equipment manufacturer (“OEM”) or commercial OEM program award with at least a 50,000 unit volume
|
|
|
|
|
|
|
|
| Program award 1 | Segment |
|
|
|
|
50,000
|
|
|
|
|
|
|
|
| Trading price of the common stock |
|
|
|
|
$ 38,000
|
|
|
|
|
|
|
|
| Fixed consideration |
|
|
|
|
|
|
$ 7,500,000
|
|
|
|
|
|
| Gain on Fair Value Instrument |
|
|
|
|
|
|
$ 1,700,000
|
|
|
|
|
|
| Convertible Senior Notes [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary or Equity Method Investee [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock, shares issued | shares |
|
|
|
|
|
|
|
|
149,037
|
|
|
|
| Sale of Stock, Price Per Share | $ / shares |
|
|
|
|
|
$ 15.8643
|
|
|
|
|
|
|
| Debt instrument convertible threshold trading days | Days |
|
|
|
|
|
|
20
|
|
|
|
|
|
| Fixed price per share | $ / shares |
|
|
|
|
|
$ 15.8643
|
|
|
|
|
|
|
| Convertible Note, Description |
|
|
|
|
|
|
The Company may redeem for cash all or any portion of the Convertible Notes, at its option, on or after November 20, 2028, if the last reported sale price of the Company’s common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption. The redemption price will be equal to 100% of the principal amount of the notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the redemption date. The Company may redeem for cash all of the Notes, at a redemption price equal to the principal amount of the Notes to be redeemed, plus accrued and unpaid interest thereon, if at any time less than 10% of the aggregate principal amount of the Notes initially issued on the date of the Indenture remain outstanding.
|
|
|
|
|
|
| Issue Amount Of Debt |
|
|
|
|
|
$ 100,000,000
|
|
|
|
|
|
|
| Interest Rate |
|
|
|
|
|
4.375%
|
100.00%
|
|
|
|
4.375%
|
|
| Effective interest rate of the Convertible Notes |
|
|
|
|
|
4.95%
|
|
|
|
|
|
|
| Convertion of share | shares |
|
|
|
|
|
63.0348
|
|
|
|
|
|
|
| Debt Conversion, Converted Instrument, Amount |
|
|
|
|
|
$ 1,000,000
|
$ 1,000,000
|
|
|
|
|
|
| Repurchase price of convertible note |
|
|
|
|
|
|
1,000,000
|
|
|
|
|
|
| Proceeds from Debt, Net of Issuance Costs |
|
|
|
|
|
$ 96,700,000
|
|
|
|
|
|
|
| Public Offering [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary or Equity Method Investee [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock, shares issued | shares |
5,168,539
|
5,168,539
|
|
|
|
|
|
|
|
|
|
|
| Additionally shares of common stock sold | shares |
674,157
|
674,157
|
|
|
|
|
|
|
|
|
|
|
| Sale of Stock, Price Per Share | $ / shares |
$ 22.25
|
$ 22.25
|
|
|
|
|
|
|
|
|
|
|
| Offering expenses |
$ 108,800,000
|
|
|
|
|
|
|
|
|
|
|
|
| Fixed price per share | $ / shares |
$ 22.25
|
$ 22.25
|
|
|
|
|
|
|
|
|
|
|
| Discount and commission |
$ 5,800,000
|
|
|
|
|
|
|
|
|
|
|
|
| Aggregate public offering price |
115,000,000
|
|
|
|
|
|
|
|
|
|
|
|
| Public offering cost |
$ 400,000
|
|
|
|
|
|
|
|
|
|
|
|
| Private Placement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary or Equity Method Investee [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock, shares issued | shares |
|
|
3,509,719
|
|
|
|
|
|
|
|
|
|
| Share price | $ / shares |
|
|
$ 9.26
|
|
|
|
|
|
|
|
|
|
| Proceeds from issuance of common stock |
|
|
$ 32,500,000
|
|
|
|
|
|
|
|
|
|
| Subscription Agreements [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary or Equity Method Investee [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock, shares issued | shares |
|
|
|
|
7,360,460
|
|
|
|
|
|
|
|
| Common stock, par value | $ / shares |
|
|
|
|
$ 0.0001
|
|
|
|
|
|
|
|
| Share price | $ / shares |
|
|
|
|
$ 2.9
|
|
|
|
|
|
|
|
| Proceeds from issuance of common stock |
|
|
|
|
$ 21,400,000
|
|
|
|
|
|
|
|
| Standby Equity Purchase Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary or Equity Method Investee [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Share price | $ / shares |
|
|
|
|
$ 10,000
|
|
|
|
|
|
|
|
| Preferred stock liquidation preference per share | $ / shares |
|
|
|
|
$ 12,000
|
|
|
|
|
|
|
|
| Percentage of dividend payble |
|
|
|
|
7.00%
|
|
|
|
|
|
|
|
| Convertible preferred stock nonredeemable or redeemable issuer option value |
|
|
|
|
$ 10,000,000
|
|
|
|
|
|
|
|
| Common stock applicable conversion price |
|
|
|
|
250.00%
|
|
|
|
|
|
|
|
| Facility fee |
|
|
|
|
|
|
2,500,000
|
|
|
|
|
|
| Origination fee |
|
|
|
|
|
|
600,000
|
|
|
|
|
|
| Administrative fees expense |
|
|
|
|
|
|
300,000
|
|
|
|
|
|
| Fees and expenses of the investor and its counsel |
|
|
|
|
|
|
$ 400,000
|
|
|
|
|
|
| Standby Equity Purchase Agreement [Member] | Series A One [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary or Equity Method Investee [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock, shares outstanding | shares |
|
|
|
|
|
|
16,428,553
|
|
|
|
|
|
| Warrants issued | shares |
|
|
|
|
|
|
|
|
|
|
|
3,000,000
|
| Standby Equity Purchase Agreement [Member] | Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary or Equity Method Investee [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Total preferred facility |
|
|
|
|
$ 125,000,000
|
|
|
|
|
|
|
|
| Standby Equity Purchase Agreement [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary or Equity Method Investee [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock, shares outstanding | shares |
|
|
|
|
16,428,553
|
|
|
|
|
|
|
|
| Standby Equity Purchase Agreement [Member] | Common Stock [Member] | Series A One [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary or Equity Method Investee [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants issued to purchase shares of common stock, Exercise price | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
$ 5
|
| Number of warrants outstanding | Warrants | Warrants |
|
|
|
|
|
|
3,000,000
|
|
|
|
|
|
| Standby Equity Purchase Agreement [Member] | Maximum [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary or Equity Method Investee [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Debt instrument convertible threshold trading days | Days |
|
|
|
|
30
|
|
|
|
|
|
|
|
| Standby Equity Purchase Agreement [Member] | Maximum [Member] | Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary or Equity Method Investee [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares preferred stock aggregate value |
|
|
|
|
$ 50,000,000
|
|
|
|
|
|
|
|
| Standby Equity Purchase Agreement [Member] | Minimum [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary or Equity Method Investee [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Debt instrument convertible threshold trading days | Days |
|
|
|
|
20
|
|
|
|
|
|
|
|
| Standby Equity Purchase Agreement [Member] | Minimum [Member] | Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary or Equity Method Investee [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares preferred stock aggregate value |
|
|
|
|
$ 25,000,000
|
|
|
|
|
|
|
|
| LG Subscription Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary or Equity Method Investee [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Sale of Stock, Price Per Share | $ / shares |
|
|
|
$ 9.26
|
|
|
|
|
|
|
|
|
| Strategic investment |
|
|
|
$ 32,500,000
|
|
|
|
|
|
|
|
|
| Fixed price per share | $ / shares |
|
|
|
$ 9.26
|
|
|
|
|
|
|
|
|
| Ownership limit percentage |
|
|
|
9.90%
|
|
|
|
|
|
|
|
|
| LG Subscription Agreement [Member] | Maximum [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary or Equity Method Investee [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Sale of Stock, Price Per Share | $ / shares |
|
|
|
$ 7.41
|
|
|
|
|
|
|
|
|
| Fixed price per share | $ / shares |
|
|
|
$ 7.41
|
|
|
|
|
|
|
|
|